Clinical and Pathological Complete Remission in a Patient With Metastatic Renal Cell Carcinoma (mRCC) Treated With Sunitinib: Is mRCC Curable With Targeted Therapy?

We report a patient with metastatic clear-cell renal cell carcinoma (mRCC) who presented with primary tumor in situ in the left kidney and metastases to bone, liver, lungs, and brain. After over 5 years of sunitinib therapy and subsequent cytoreductive left nephrectomy, the patient achieved radiogra...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Urol Case Rep
Autors principals: Shah, Amishi Y., Karam, Jose A., Lim, Zita D., Ng, Chaan S., Tannir, Nizar M.
Format: Artigo
Idioma:Inglês
Publicat: Elsevier 2015
Matèries:
Oncology
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4477704/
https://ncbi.nlm.nih.gov/pubmed/26120560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eucr.2014.12.011
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars